Identity & documentation
Look for clear product labeling, lot identification, and accessible third-party documentation tied to the item you are reviewing.
An independent research-buyer checklist
Better questions before you buy.
A short, practical framework for reviewing peptide research vendors—plus transparent affiliate links for readers who choose one of our featured partners.
THE 3-POINT REVIEW
Documentation should answer your questions before marketing does.
01
Can you match the report to the product and lot?
02Is the laboratory and test method clearly identified?
03Are purchase policies and support easy to find?
START HERE
Four research briefs, one clear standard.
Each issue separates mechanism, evidence level, and marketing language—then links readers to the underlying source.
01 · GH AXIS
Tesamorelin & ipamorelin
Two receptor pathways, with an important distinction between an approved indication and investigational evidence.
Read the evidence 02 · MITOCHONDRIAMOTS-c & elamipretide
Metabolic signaling and inner-membrane targeting—and what human evidence does not yet show.
Read the evidence 03 · REPAIRBPC-157 & TB-500
Why the popular “Wolverine” label runs ahead of the available human evidence.
Read the evidence 04 · BUYER LITERACYHow to read a peptide COA
Lot matching, laboratory identity, methods, purity, identity, and the claims a certificate cannot support.
Read the evidenceBEFORE CHECKOUT
A five-minute buyer review
This checklist does not certify a vendor or replace professional advice. It helps you slow down and verify the basics.
Independent testing
Review the stated laboratory, test date, method, and whether the report matches the product and lot—not simply the compound name.
Policies & support
Read shipping, replacement, storage, and customer-service policies before ordering. Save your confirmation and documentation.
FREE DOWNLOAD
Send me the guide Take the full seven-point field guide.
Get the printable checklist, a COA reading guide, six red flags, and a simple record sheet.
RESEARCH, NOT RECOMMENDATIONS
What scientists are actually studying
Peptides are often grouped by the biological pathway they influence. That does not mean every compound—or any popular “stack”—has been shown to be safe or effective in people.
Approved, specific indication Human research Primarily preclinical
ENDOCRINE SIGNALING
Growth-hormone release pathways
FDA-approved for a specific use
Tesamorelin
A stabilized analog of growth-hormone-releasing hormone (GHRH).
It binds pituitary GHRH receptors and stimulates endogenous, pulsatile growth-hormone release, increasing downstream IGF-1. Its U.S. approval is specifically for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. The label says it is not indicated for weight-loss management.
FDA prescribing informationEarly human pharmacology
Ipamorelin
A synthetic agonist of the ghrelin/growth-hormone secretagogue receptor.
Rather than acting through the GHRH receptor, ipamorelin activates GHSR signaling to prompt pituitary GH release. A small healthy-volunteer study showed a brief GH pulse, but a randomized Phase 2 trial did not significantly improve its primary clinical endpoint. Ipamorelin is not FDA approved.
Human PK/PD studyWhy they are discussed together: GHRH-receptor and GHSR signaling are two upstream routes to endogenous GH release. That mechanistic complement is biologically plausible, but it is not proof that combining tesamorelin and ipamorelin improves outcomes or is safe. We found no controlled human combination trial.
CELLULAR ENERGY
Mitochondrial peptides
Preclinical + observational human data
MOTS-c
A 16-amino-acid peptide encoded within mitochondrial DNA.
Cell and mouse studies connect MOTS-c with metabolic-stress signaling, AMPK-related pathways, glucose handling, and physical performance. Human studies have measured endogenous MOTS-c, including changes after exercise, but published studies have not established efficacy or safety after administering native MOTS-c to people.
Exercise and aging studyAccelerated approval: Barth syndrome
Elamipretide (SS-31)
A mitochondrial cardiolipin-binding peptide.
Elamipretide associates with cardiolipin at the inner mitochondrial membrane. In 2025, the FDA granted accelerated approval for improving muscle strength in patients with Barth syndrome weighing at least 30 kg, with a confirmatory trial required. A larger trial in primary mitochondrial myopathy had previously missed both primary endpoints.
FDA prescribing informationWhat “mitochondrial synergy” would mean: MOTS-c is studied mainly as a stress-responsive signaling peptide, while elamipretide targets the inner mitochondrial membrane. They address different layers of mitochondrial biology, but we found no reliable human trial establishing that a MOTS-c + elamipretide combination works better than either alone.
TISSUE REPAIR
So-called “healing peptides”
Primarily rodent & cell research
BPC-157
A synthetic 15-amino-acid peptide studied in injury models.
Laboratory and rodent studies report effects involving tendon-cell migration, outgrowth, vascular signaling, and healing in several tissues. FDA’s 2026 review found only very small or incomplete human reports and judged the clinical safety and effectiveness evidence insufficient.
Rat tendon studyHuman data are for thymosin β4
TB-500 / thymosin β4
TB-500 is an N-acetylated fragment related to, but not identical with, full-length thymosin β4.
Full-length thymosin β4 has human research, but FDA’s 2026 review found no human exposure or clinical studies of TB-500 itself. Results for the 43-amino-acid parent peptide or a non-acetylated fragment cannot be assumed to apply to TB-500.
FDA evidence reviewAbout the “Wolverine stack”: This is an informal marketing nickname for BPC-157 plus TB-500—not a recognized clinical protocol. No registered human trial tests the pair together, so claims of faster recovery or synergy are not established. Both are prohibited at all times under the 2026 World Anti-Doping Code list .
Keep the evidence level attached to the claim.
Animal findings can explain why a compound interests researchers, but they cannot predict a person’s benefit, dose, interactions, contamination risk, or long-term safety. This library is educational and does not advise purchase, injection, or self-treatment. Evidence reviewed October 2, 2026.
RESEARCH PARTNERS
Two highly reputable suppliers, selected for their published testing standards.
We regard Middle Man Peptides and Disguised Alpha as highly reputable research suppliers because both report independent third-party testing and make batch documentation available to researchers.
VETERAN & FAMILY OWNED
Middle Man Peptides
A highly reputable research supplier that reports independent, third-party testing and provides batch-specific Certificates of Analysis.
- Independent laboratory testing
- Batch-specific COAs
Affiliate code
Visit Middle Man & save 20% REVITALIZE
20% off your first order. Use this code at checkout on the partner website. Cannot be combined with any other offer.
8-PANEL BATCH TESTING
Disguised Alpha
A highly reputable research supplier that reports independent, third-party eight-panel batch testing, with Certificates of Analysis available before purchase.
- Identity and purity
- Sterility and endotoxin
- Heavy-metals screening
10% off a first order for new customers using this referral link. Current pricing and offer terms are set by the partner.
How we use “reputable”: This assessment reflects our opinion and each company’s published testing practices. The Research Standard has not independently audited, tested, or certified either supplier, so always match the current COA to the product and lot.
TRANSPARENCY
Know what this page is—and isn’t.
Affiliate disclosure
We may receive compensation when a visitor purchases through one of our links or uses our code. That relationship does not increase the visitor’s price.
Educational scope
This site is general information only. It does not provide medical advice, diagnosis, treatment, dosing, or an endorsement of self-administration.
Subscriber privacy
We store your email, consent record, and subscription status and use MailerLite to deliver messages. We do not sell subscriber addresses. Every email includes an unsubscribe link.
Editorial standard
We link primary or official sources, label evidence type, date material reviews, and welcome corrections at brief@theresearchstandard.com.